Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for IFTBF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
March 31, 2026 8.668M
December 31, 2025 11.43M
September 30, 2025 13.22M
June 30, 2025 14.10M
March 31, 2025 15.28M
December 31, 2024 15.41M
September 30, 2024 20.13M
June 30, 2024 22.35M
March 31, 2024 25.94M
December 31, 2023 30.28M
September 30, 2023 31.85M
June 30, 2023 26.01M
March 31, 2023 29.82M
December 31, 2022 31.84M
September 30, 2022 33.50M
June 30, 2022 37.04M
March 31, 2022 40.35M
December 31, 2021 43.66M
September 30, 2021 47.03M
Date Value
June 30, 2021 48.12M
March 31, 2021 50.56M
December 31, 2020 53.60M
September 30, 2020 51.96M
June 30, 2020 51.91M
March 31, 2020 51.63M
December 31, 2019 54.52M
September 30, 2019 54.71M
June 30, 2019 59.11M
March 31, 2019 59.95M
December 31, 2018 62.79M
September 30, 2018 65.32M
June 30, 2018 65.93M
March 31, 2018 70.35M
December 31, 2017 20.56M
September 30, 2017 9.680M
June 30, 2017 9.912M
March 31, 2017 10.83M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Orexo AB 28.03M
Swedencare AB 733.43M
Camurus AB 483.59M
Moberg Pharma AB 68.50M
AstraZeneca PLC 47.33B

Shareholders Equity (Quarterly) Related Metrics